Yuli Li Selected Research

oxymatrine

4/2002

Effect of oxymatrine on murine fulminant hepatitis and hepatocyte apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuli Li Research Topics

Disease

7	Neoplasms (Cancer) 04/2024 - 03/2004
4	COVID-19 11/2023 - 12/2022
2	Schizophrenia (Dementia Praecox) 01/2024 - 07/2021
2	Breast Neoplasms (Breast Cancer) 11/2022 - 05/2013
2	Chronic Pain 10/2022 - 09/2015
2	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2013
2	Wounds and Injuries (Trauma) 01/2013 - 08/2012
1	Glioma (Gliomas) 04/2024
1	Hypertension (High Blood Pressure) 01/2024
1	Major Depressive Disorder (Major Depressive Disorders) 01/2024
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2024
1	Hypertriglyceridemia 01/2024
1	Prediabetic State (Prediabetes) 01/2024
1	Venous Thromboembolism 11/2023
1	Pulmonary Embolism 11/2023
1	Frailty 01/2023
1	Opioid-Related Disorders (Opiate Addiction) 10/2022
1	Macular Degeneration (Age-Related Maculopathy) 01/2022
1	Infertility (Sterility) 01/2022
1	Epilepsy (Aura) 12/2021
1	Mental Disorders (Mental Disorder) 07/2021
1	Gastritis 06/2021
1	Reinfection 06/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Alcoholism (Alcohol Abuse) 01/2019
1	Adenocarcinoma 01/2019
1	Craniocerebral Trauma (Head Injury) 01/2018
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018
1	Chromosome Breakage 01/2017
1	Reperfusion Injury 01/2014
1	Brain Ischemia (Cerebral Ischemia) 01/2014
1	Toxic Optic Neuropathy 02/2012
1	Melanoma (Melanoma, Malignant) 03/2011
1	Massive Hepatic Necrosis 04/2002
1	Necrosis 04/2002

Drug/Important Bio-Agent (IBA)

4	nirmatrelvir and ritonavir drug combinationIBA 11/2023 - 12/2022
3	molnupiravirIBA 01/2023 - 12/2022
2	Antiviral Agents (Antivirals)IBA 11/2023 - 01/2023
2	Proto-Oncogene Proteins c-fos (FRAs)IBA 11/2022 - 12/2021
2	Opioid Analgesics (Opioids)IBA 10/2022 - 09/2015
2	LipopolysaccharidesIBA 11/2014 - 04/2002
1	Small Nuclear RNA (snRNA)IBA 04/2024
1	5-hydroxymethylcytosineIBA 04/2024
1	5-Methylcytosine (5 Methylcytosine)IBA 04/2024
1	RNA (Ribonucleic Acid)IBA 04/2024
1	Metformin (Glucophage)FDA LinkGeneric 01/2024
1	insulin receptor-related receptor (IRR)IBA 01/2024
1	bebtelovimabIBA 01/2023
1	sotrovimabIBA 01/2023
1	BuffersIBA 01/2022
1	alectinibIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 02/2020
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Glycyrrhetinic Acid (Po 12)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Monoclonal AntibodiesIBA 11/2014
1	VaccinesIBA 11/2014
1	Sheng-Nao-KangIBA 01/2014
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2013
1	15-hydroxyprostaglandin dehydrogenaseIBA 05/2013
1	Dinoprostone (PGE2)FDA Link 05/2013
1	Celecoxib (Celebrex)FDA Link 05/2013
1	HydrogelsIBA 01/2013
1	Ointments (Pastes)IBA 08/2012
1	PowdersIBA 08/2012
1	Polymethyl Methacrylate (Sol)IBA 08/2012
1	Petrolatum (Vaseline)FDA Link 08/2012
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 02/2012
1	SuspensionsIBA 02/2012
1	Retinaldehyde (Retinal)IBA 03/2011
1	9-((2-phosphonylmethoxy)ethyl)guanineIBA 03/2011
1	AgarIBA 03/2004
1	Fas Ligand Protein (Fas Ligand)IBA 04/2002
1	GalactosamineIBA 04/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2002
1	oxymatrineIBA 04/2002

Therapy/Procedure

5	Therapeutics 04/2024 - 05/2013
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 06/2021
1	Pain Management 01/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Precision Medicine 07/2021